Nordic Biosciences

Nordic Bioscience is a Danish private life science company focused on extracellular matrix biology, blood-based protein biomarkers, and laboratory services that support drug development and precision medicine. The company commercializes proprietary biomarker assays and panels, including its Nordic ProteinFingerPrint Technology platform, for use in preclinical and clinical studies across fibrosis, inflammation, oncology, metabolic disease, rheumatology, and other chronic disorders. In addition to research-use biomarker kits and central laboratory services, Nordic Bioscience has a diagnostics effort and a partnered drug-development pipeline built around ECM biology. The company is particularly known for collagen- and matrix-remodeling biomarkers such as PRO-C3 and PRO-C6/endotrophin, which are used to stratify patients, assess pharmacodynamic effects, and support clinical trial design. Nordic Bioscience also operates with regulatory-grade laboratory capabilities and collaborates broadly with pharmaceutical, biotech, CRO, and diagnostics partners.